Stock Scorecard
Stock Summary for Johnson & Johnson (JNJ) - $223.51 as of 6/2/2026 11:21:27 AM EST
Total Score
9 out of 30
Safety Score
56 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for JNJ
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for JNJ
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for JNJ
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for JNJ
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for JNJ (56 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for JNJ
Financial Details for JNJ
Company Overview |
|
|---|---|
| Ticker | JNJ |
| Company Name | Johnson & Johnson |
| Country | N/A |
| Description | Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 223.51 |
| Price 4 Years Ago | 159.52 |
| Last Day Price Updated | 6/2/2026 11:21:27 AM EST |
| Last Day Volume | 8,040,997 |
| Average Daily Volume | 7,782,666 |
| 52-Week High | 251.71 |
| 52-Week Low | 146.24 |
| Last Price to 52 Week Low | 52.84% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 25.94 |
| Sector PE | 59.49 |
| 5-Year Average PE | 30.51 |
| Free Cash Flow Ratio | 24.81 |
| Industry Free Cash Flow Ratio | 25.79 |
| Sector Free Cash Flow Ratio | 25.42 |
| Current Ratio Most Recent Quarter | 1.03 |
| Total Cash Per Share | 9.01 |
| Book Value Per Share Most Recent Quarter | 33.73 |
| Price to Book Ratio | 6.95 |
| Industry Price to Book Ratio | 8.98 |
| Sector Price to Book Ratio | 9.57 |
| Price to Sales Ratio Twelve Trailing Months | 5.85 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.10 |
| Sector Price to Sales Ratio Twelve Trailing Months | 9.36 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 2,407,217,000 |
| Market Capitalization | 538,037,071,670 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 5/26/2026 |
| Previous Dividend Amount | 1.3000 |
| Current Dividend Amount | 1.3400 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 5.24 |
| Trailing Annual Dividend Yield | 2.33% |
| Forward Annual Dividend Rate | 5.36 |
| Forward Annual Dividend Yield | 2.38% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 2.51% |
| 5-Year Average Dividend Yield | 3.02% |
| 1-Year Dividend Growth Rate Percentage | 4.28% |
| 3-Year Dividend Growth Rate Percentage | 2.12% |
| 5-Year Dividend Growth Rate Percentage | 4.76% |
| All-Time Dividend Growth Rate Percentage | 12.87% |
| Dividend Payout Ratio | 60.79% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -52.90% |
| Annual Earnings Growth | 90.56% |
| Reported EPS 12 Trailing Months | 8.62 |
| Reported EPS Past Year | 2.70 |
| Reported EPS Prior Year | 10.80 |
| Net Income Twelve Trailing Months | 21,040,000,000 |
| Net Income Past Year | 26,804,000,000 |
| Net Income Prior Year | 14,066,000,000 |
| Quarterly Revenue Growth YOY | 9.90% |
| 5-Year Revenue Growth | 2.67% |
| Operating Margin Twelve Trailing Months | 27.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 21,688,000,000 |
| Total Cash Past Year | 19,709,000,000 |
| Total Cash Prior Year | 24,105,000,000 |
| Net Cash Position Most Recent Quarter | -15,839,000,000 |
| Net Cash Position Past Year | -19,729,000,000 |
| Long Term Debt Past Year | 39,438,000,000 |
| Long Term Debt Prior Year | 30,651,000,000 |
| Total Debt Most Recent Quarter | 37,527,000,000 |
| Equity to Debt Ratio Past Year | 0.67 |
| Equity to Debt Ratio Most Recent Quarter | 0.68 |
| Total Stockholder Equity Past Year | 81,544,000,000 |
| Total Stockholder Equity Prior Year | 71,490,000,000 |
| Total Stockholder Equity Most Recent Quarter | 81,186,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 17,798,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 7.39 |
| Free Cash Flow Past Year | 19,698,000,000 |
| Free Cash Flow Prior Year | 19,842,000,000 |
Options |
|
| Put/Call Ratio | 1.40 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.08 |
| MACD Signal | -0.96 |
| 20-Day Bollinger Lower Band | 215.46 |
| 20-Day Bollinger Middle Band | 232.43 |
| 20-Day Bollinger Upper Band | 249.41 |
| Beta | 0.26 |
| RSI | 52.03 |
| 50-Day SMA | 199.85 |
| 150-Day SMA | 164.97 |
| 200-Day SMA | 161.17 |
System |
|
| Modified | 6/2/2026 2:01:45 AM EST |